Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients

Olearo, Flamina; Nguyen, Huyen Tran; Bonnet, Fabrice Henri Georges; Yerly Ferrillo, Sabine; Wandeler, Gilles; Stoeckle, Marcel; Cavassini, Matthias; Scherrer, Alexandra; Costagliola, Dominique; Schmid, Patrick; Günthard, Huldrych F; Bernasconi, Enos; Boeni, Jürg; D'arminio Monforte, Antonella; Zazzi, Maurizio; Rossetti, Barbara; Neau, Didier; Bellecave, Pantxika; Rijnders, Bart; Reiss, Peter; Wit, Ferdinand; Kouyos, Roger; Calmy, Alexandra

doi:10.1093/ofid/ofz330

Scientific article

English

Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients

Errata

Corrigendum: surname of a co-author, Dominique Costagliola, was misspelled
DOI : 10.1093/ofid/ofz500
PMID : 31832485

Published inOpen Forum Infectious Diseases, vol. 6, no. 10

Publication date2019

Abstract

The impact of the M184V/I mutation on the virological failure (VF) rate in HIV-positive patients with suppressed viremia switching to an abacavir/lamivudine/dolutegravir regimen has been poorly evaluated.

Keywords

ABC/3TC/DTG
M184V/I
Treatment-experienced patients
Virological failure

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Funding

Swiss National Science Foundation - #177499
Swiss National Science Foundation - #BSSGI0_155851

Citation (ISO format)

OLEARO, Flamina et al. Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients. In: Open Forum Infectious Diseases, 2019, vol. 6, n° 10. doi: 10.1093/ofid/ofz330

Article (Published version)

CC BY-NC-ND

Appendix

Corrigendum

Identifiers

PID : unige:145511
DOI : 10.1093/ofid/ofz330
PMID : 31660328

Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778427/

Journal ISSN2328-8957

307views

270downloads

Creation13/10/2020 12:06:00

First validation13/10/2020 12:06:00

Update09/02/2026 15:27:31

Status update09/02/2026 15:27:31

Last indexation09/02/2026 15:32:55

Archive ouverte UNIGE

Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients

The impact of the M184V/I mutation on the virological failure (VF) rate in HIV-positive patients with suppressed viremia switching to an abacavir/lamivudine/dolutegravir regimen has been poorly evaluated.

Technical informations